Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1980 May;40(2):327–336.

An in vitro assessment of cellular and humoral immune function in pulmonary tuberculosis: correction of defective neutrophil motility by ascorbate, levamisole, metoprolol and propranolol.

E M Gatner, R Anderson
PMCID: PMC1536972  PMID: 7002387

Abstract

Fifty-six tuberculosis patients and twenty-eight control subjects were evaluated in a comprehensive investigation of cellular and humoral immune function in pulmonary TB. The patient group showed significantly higher levels of secretory IgA and serum IgG, IgA and IgM than did the control group but 7% of patients displayed a selective secretory IgA deficiency. Levels of alpha-1-antitrypsin were also significantly higher in the patient group. There were no significant differences in levels of total haemolytic complement, C'3 and C'4. In moderate to moderately advanced TB patients there were no significant differences in T and B cell numbers nor in mitogen-induced lymphocyte transformation and lymphokine production, when compared with the control group. The range of PPD-induced lymphocyte transformation and lymphokine production levels encountered was similar in both groups although certain patients did not respond to the PPD antigen. Neutrophils from TB patients showed increased random motility in vitro but eight out of ten patients showed impaired directed motility (chemotaxis). Phagocytic and anti-microbial functions were normal in the patient group. The neutrophil chemotactic defect was reversible and could be corrected in vitro when the patients' cells were treated with sodium and calcium ascorbate, levamisole, metoprolol and propranolol.

Full text

PDF
327

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson R., Glover A., Koornhof H. J., Rabson A. R. In vitro stimulation of neutrophil motility by levamisole: maintenance of cgmp levels in chemotactically stimulated levamisole-treated neutrophils. J Immunol. 1976 Aug;117(2):428–432. [PubMed] [Google Scholar]
  2. Anderson R. Stimulation of normal and abnormal neutrophil motility in vitro by dexpropranolol, metoprolol and sotalol. S Afr Med J. 1979 Aug 4;56(5):165–165. [PubMed] [Google Scholar]
  3. Anderson R., Theron A. Effects of ascorbate on leucocytes: Part I. Effects of ascorbate on neutrophil motility and intracellular cyclic nucleotide levels in vitro. S Afr Med J. 1979 Sep 1;56(10):394–400. [PubMed] [Google Scholar]
  4. Anderson R., van Rensburg A. J. The in vitro effects of propranolol and atenolol on neutrophil motility and post-phagocytic metabolic activity. Immunology. 1979 May;37(1):15–24. [PMC free article] [PubMed] [Google Scholar]
  5. Brain P., Marston R. H. Rosette formation by human T and B lymphocytes. Eur J Immunol. 1973 Jan;3(1):6–9. doi: 10.1002/eji.1830030103. [DOI] [PubMed] [Google Scholar]
  6. Campbell P. B. Defective leukotaxis in monocytes from patients with pulmonary tuberculosis. J Infect Dis. 1979 Apr;139(4):409–417. doi: 10.1093/infdis/139.4.409. [DOI] [PubMed] [Google Scholar]
  7. Casterline C. L., Evans R., 3rd, Ward G. W., Jr Quantitative levels of immunoglobulin E in advanced tuberculosis. Chest. 1976 Jul;70(1):21–23. doi: 10.1378/chest.70.1.21. [DOI] [PubMed] [Google Scholar]
  8. Ellner J. J. Suppressor adherent cells in human tuberculosis. J Immunol. 1978 Dec;121(6):2573–2579. [PubMed] [Google Scholar]
  9. Geisler L. S., Bachmann G. W., Laumen F., Nolte D., Wentzel H., Rost H. D. 1 -Antitrypsin und Immunglobuline bei chronisch unspezifischen Lungenerkrankungen und Lungentuberkulose. Dtsch Med Wochenschr. 1972 Mar 3;97(9):329–passim. doi: 10.1055/s-0028-1107350. [DOI] [PubMed] [Google Scholar]
  10. Goetzl E. J., Wasserman S. I., Gigli I., Austen K. F. Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J Clin Invest. 1974 Mar;53(3):813–818. doi: 10.1172/JCI107620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hill H. R., Gerrard J. M., Hogan N. A., Quie P. G. Hyperactivity of neutrophil leukotactic responses during active bacterial infection. J Clin Invest. 1974 Apr;53(4):996–1002. doi: 10.1172/JCI107666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jha V. K., Bajpai B. K., Gupta R. M. Levels of serum immunoglobulins in pulmonary tuberculosis patients. Indian J Chest Dis. 1974 Oct;16(4):361–367. [PubMed] [Google Scholar]
  13. Kvetny J. T-lymphocyte determination in tuberculosis. Scand J Respir Dis. 1977 Jun;58(3):181–184. [PubMed] [Google Scholar]
  14. Lenzini L., Rottoli P., Rottoli L. The spectrum of human tuberculosis. Clin Exp Immunol. 1977 Feb;27(2):230–237. [PMC free article] [PubMed] [Google Scholar]
  15. Maini R. N., Beck A., Roffe L. A study of delayed hypersensitivity, lymphocyte transformation and leucocyte migration inhibition by M. xenopi and M. tuberculosis in patients harbouring these organisms. Tubercle. 1974 Dec;55(4):269–281. doi: 10.1016/0041-3879(74)90036-1. [DOI] [PubMed] [Google Scholar]
  16. Malaviya A. N., Sehgal K. L., Kumar R., Dingley H. B. Factors of delayed hypersensitity in pulmonary tuberculosis. Am Rev Respir Dis. 1975 Jul;112(1):49–52. doi: 10.1164/arrd.1975.112.1.49. [DOI] [PubMed] [Google Scholar]
  17. Malomo I. M., McFarlane H., Idowu J. A. Serum immunoglobulins in pulmonary tuberculosis in Ibadan Nigeria. Trans R Soc Trop Med Hyg. 1970;64(3):427–430. doi: 10.1016/0035-9203(70)90180-x. [DOI] [PubMed] [Google Scholar]
  18. Mowat A. G., Baum J. Polymorphonuclear leucocyte chemotaxis in patients with bacterial infections. Br Med J. 1971 Sep 11;3(5775):617–619. doi: 10.1136/bmj.3.5775.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pauw F. H., du P Heyns A. The effect of oral isoniazid on human lymphocyte subpopulations. S Afr Med J. 1979 Jan 20;55(3):86–88. [PubMed] [Google Scholar]
  20. Poh S. C., Seet A. M. Alpha1 antitrypsin levels in chronic obstructive lung disease and pulmonary tuberculosis in Singapore. Singapore Med J. 1975 Jun;16(2):89–91. [PubMed] [Google Scholar]
  21. Root R. K., Stossel T. P. Myeloperoxidase-mediated iodination by granulocytes. Intracellular site of operation and some regulating factors. J Clin Invest. 1974 May;53(5):1207–1215. doi: 10.1172/JCI107667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sher R., Anderson R., Rabson A. R., Koornhof H. J. Standardisation of the nitro-blue tetrazolium test and factors affecting its clinical application. S Afr Med J. 1974 Feb 9;48(6):209–212. [PubMed] [Google Scholar]
  23. WOOD H. G., KATZ J., LANDAU B. R. ESTIMATION OF PATHWAYS OF CARBOHYDRATE METABOLISM. Biochem Z. 1963;338:809–847. [PubMed] [Google Scholar]
  24. Weisbart R. H., Mickey M. R. A microassay for leukocyte migration: analysis of its reproducibility. J Immunol Methods. 1977;16(3):269–281. doi: 10.1016/0022-1759(77)90204-6. [DOI] [PubMed] [Google Scholar]
  25. Williams R. C., Jr, DeBoard J. R., Mellbye O. J., Messner R. P., Lindström F. D. Studies of T- and B-lymphocytes in patients with connective tissue diseases. J Clin Invest. 1973 Feb;52(2):283–295. doi: 10.1172/JCI107184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Zeitz S. J., Ostrow J. H., Van Arsdel P. P., Jr Humoral and cellular immunity in the anergic tuberculosis patient. A prospective study. J Allergy Clin Immunol. 1974 Jan;53(1):20–26. doi: 10.1016/0091-6749(74)90095-5. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES